title: More on ADORA.
authors.forename: Amy
authors.initials: A
authors.lastname: Yang
authors.forename: Emma
authors.initials: E
authors.lastname: Childs
authors.forename: Abraham A
authors.initials: AA
authors.lastname: Palmer
authors.forename: Harriet
authors.initials: H
authors.lastname: de Wit
mesh_terms: D001007:Anxiety / Q000139:chemically induced* / Q000235:genetics; D002110:Caffeine / Q000009:adverse effects* / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000378:metabolism; D003069:Coffee / Q000009:adverse effects; D004327:Drinking Behavior; D005247:Feeding Behavior; D020022:Genetic Predisposition to Disease; D006801:Humans; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D043682:Receptor, Adenosine A1 / Q000235:genetics*; D043705:Receptor, Adenosine A2A / Q000235:genetics*
chemical_list: D000697:Central Nervous System Stimulants; D003069:Coffee; D043682:Receptor, Adenosine A1; D043705:Receptor, Adenosine A2A; D002110:Caffeine
references.citation: Neuropsychopharmacology. 2003 Sep;28(9):1694-702
references.pmid: 12825092
references.citation: Neuropsychopharmacology. 2008 Nov;33(12):2791-800
references.pmid: 18305461
references.citation: Am J Clin Nutr. 2007 Jul;86(1):240-4
references.pmid: 17616786
references.citation: Neuropsychopharmacology. 2010 Aug;35(9):1973-83
references.pmid: 20520601
references.citation: Psychopharmacology (Berl). 2010 Aug;211(3):245-57
references.pmid: 20532872